Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML
Leukemia
.
2018 Apr;32(4):1054.
doi: 10.1038/leu.2017.348.
Epub 2018 Jan 30.
Authors
C Schütz
,
S Inselmann
,
S Saussele
,
C T Dietz
,
M C Müller
,
E Eigendorff
,
C A Brendel
,
S K Metzelder
,
T H Brümmendorf
,
C Waller
,
J Dengler
,
M E Goebeler
,
R Herbst
,
G Freunek
,
S Hanzel
,
T Illmer
,
Y Wang
,
T Lange
,
F Finkernagel
,
R Hehlmann
,
M Huber
,
A Neubauer
,
A Hochhaus
,
J Guilhot
,
F X Mahon
,
M Pfirrmann
,
A Burchert
PMID:
29381150
DOI:
10.1038/leu.2017.348
Abstract
This corrects the article DOI: 10.1038/leu.2017.9.
Publication types
Published Erratum